Cited by 324Systemic Lupus Erythematosus ResearchVenous Thromboembolism Diagnosis and ManagementBlood Coagulation and Thrombosis Mechanisms

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies

Ruiz‐Irastorza, Guillermo, Hunt, Beverley J., Khamashta, Munther A.·2007·Arthritis Care & Research

DOI 10.1002/art.23109

Open this paper in CoChat — free account

Abstract

OBJECTIVE: To systematically review the efficacy and safety data of different therapeutic approaches in patients with antiphospholipid antibodies (aPL) and thrombosis. METHODS: The Medline database and references from selected reports and review articles were used. Randomized controlled trials, prospective and retrospective cohort studies, and subgroup analysis (n > 15) that focused on the secondary thromboprophylaxis in patients with aPL were selected. RESULTS: Sixteen studies were selected. Patients with venous events and a single test for aPL showed a low recurrence rate while receiving oral anticoagulation at a target international normalized ratio (INR) of 2.0-3.0. Patients with stroke and a single positive aPL test had no increased risk compared with those without aPL. Recurrence rates in patients with definite antiphospholipid syndrome (APS) and previous venous thromboembolism were lower than in patients with arterial and/or recurrent events, both with and without therapy. Only 3.8% of recurrent events occurred at an actual INR >3.0. Mortality due to recurrent thrombosis was higher than mortality due to bleeding (18 patients versus 1 patient reported). CONCLUSION: For patients with definite APS, we recommend prolonged warfarin therapy at a target INR of 2.0-3.0 in APS patients with first venous events and >3.0 for those with recurrent and/or arterial events. For patients with venous thromboembolism or stroke and a single positive aPL test, we recommend further testing to determine if they have a persisting antibody. If they do not, the same therapy as for the general population should be used (warfarin at a target INR of 2.0-3.0 and low-dose aspirin, respectively).

Integrity signals

Registry

Crossref · 10.1002/art.23109

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
MIYAKIS, S., LOCKSHIN, M. D., ATSUMI, T., BRANCH, D. W., BREY, R. L., CERVERA, R., DERKSEN, R. H. W. M., DE GROOT, P. G., KOIKE, T., MERONI, P. L., et al. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01753.x · Cited by 7,203
Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients
Cervera, R., Piette, J., Font, J., Khamashta, M. A., Shoenfeld, Y., Camps, M. T., Jacobsen, S., Lakos, G., Tincani, A., Kontopoulou‐Griva, I., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10187 · Cited by 2,156
Antithrombotic Therapy for Venous Thromboembolic Disease
Hyers, T. M., Agnelli, G., Hull, R. D., Morris, T. A., Samama, M. M., Tapson, V. F., & Weg, J. G. (2001) · CHEST Journal · doi:10.1378/chest.119.1_suppl.176s · Cited by 2,035
The management of thrombosis in the antiphospholipid-antibody syndrome
Khamashta, M. A., Cuadrado, M. J., Mujic, F., Taub, N. A., Hunt, B. J., & Hughes, G. R. V. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504133321504 · Cited by 1,450
Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT)
Palareti, G., Leali, N., COCCHERI, S., Poggi, M., Manotti, C., D’Angelo, A., Pengo, V., Erba, N., Moia, M., CIAVARELLA, N., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)01109-9 · Cited by 1,319
Antithrombotic Therapy for Venous Thromboembolic Disease
Büller, H. R., Agnelli, G., Hull, R. D., Hyers, T. M., Prins, M. H., & Raskob, G. E. (2004) · Chest · doi:10.1378/chest.126.3_suppl.401s · Cited by 1,249
Grading Strength of Recommendations and Quality of Evidence in Clinical Guidelines
Guyatt, G., Gutterman, D., Baumann, M. H., Addrizzo-Harris, D., Hylek, E. M., Phillips, B., Raskob, G., Lewis, S. Z., & Schünemann, H. (2006) · Chest · doi:10.1378/chest.129.1.174 · Cited by 1,220
A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke
Mohr, J. P., Thompson, J. L. P., Lazar, R. M., Levin, B., Sacco, R. L., Furie, K. L., Kistler, J. P., Albers, G. W., Pettigrew, L. C., Adams, H. P., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011258 · Cited by 1,168
Hemorrhagic Complications of Anticoagulant Treatment
Levine, M. N., Raskob, G. E., Landefeld, S., & Kearon, C. (2001) · CHEST Journal · doi:10.1378/chest.119.1_suppl.108s · Cited by 1,129
A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome
Crowther, M. A., Ginsberg, J. S., Julian, J., Denburg, J., Hirsh, J., Douketis, J., Laskin, C., Fortin, P., Anderson, D., Kearon, C., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035241 · Cited by 919

Flagged first, then by citations

Show all 40 references

Sorted by citations

Items 201–300 of 323

Thrombotic antiphospholipid syndrome: From guidelines to clinical management
Paredes, D., Martín‐Iglesias, D., & Ruiz‐Irastorza, G. (2024) · Medicina Clínica · doi:10.1016/j.medcli.2024.02.010 · Cited by 6
Phospholipid inhibitors
Galli, M. (2011) · Hämostaseologie · doi:10.5482/ha-1165 · Cited by 4
Neuropsychiatric Manifestations of Systemic Lupus Erythematosus
Chen, S., & Bermas, B. L. (2019) · Springer eBooks · doi:10.1007/978-3-030-16928-2_4 · Cited by 5
A challenging case of neuropsychiatric systematic lupus erythematosus with recurrent antiphospholipid- related stroke: A case report and literature review
Shih, Y.-C., Ou, Y.-H., Chang, S., & Lin, C. (2019) · Neurology International · doi:10.4081/ni.2019.8182 · Cited by 4
Identification of anti-moesin antibodies in the serums of patients with antiphospholipid syndrome
Lin, X., Liang, Q., Lin, L., Ding, Q.-L., Wang, X., & Wang, Y. (2015) · Thrombosis Research · doi:10.1016/j.thromres.2015.02.018 · Cited by 4
Management of Thrombosis in Antiphospholipid Syndrome
Khamashta, M. A., & Ruiz‐Irastorza, G. (2006) · Springer eBooks · doi:10.1007/1-84628-009-5_43 · Cited by 4
Treatment of antiphospholipid antibody syndrome
Mehdi, A. A., Uthman, I. W., & Khamashta, M. A. (2010) · International Journal of Clinical Rheumatology · doi:10.2217/ijr.10.8 · Cited by 4
Antiphospholipid Syndrome and Kidney Involvement: New Insights
Martínez-Flores, J. A., Serrano, M., Morales, J. M., & Serrano, A. (2016) · Antibodies · doi:10.3390/antib5030017 · Cited by 6
Treatment of Systemic Lupus Erythematosus
Bertsias, G. K., Fanouriakis, A., & Boumpas, D. T. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4377-1738-9.00081-5 · Cited by 4
Treatment of Systemic Lupus Erythematosus
Bertsias, G. K., Fanouriakis, A., & Boumpas, D. T. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-31696-5.00081-4 · Cited by 3
Perioperative management of patients with hemostatic system disorders. Methodological recommendations of the All-Russian public organization “Federation of Anesthesiologists and Reanimatologists” and the National Association of Specialists in Thrombosis, Clinical Hemostasiology and Hemorheology
Zabolotskikh, I. B., Sinkov, S. V., Bulanov, А. Y., Vorobyova, N. A., Eremenko, A. A., Kuzovlev, A. N., Kulikov, A. V., Лебединский, К. М., Popov, A. S., & Ройтман, Е. В. (2024) · Annals of critical care · doi:10.21320/1818-474x-2024-1-7-46 · Cited by 3
Antiphospholipid antibodies and antiphospholipid syndrome
Hansen, R. S., Larsen, J. B., Vinholt, P. J., Voss, A., & Abildgaard, A. M. (2024) · Ugeskrift for Læger · doi:10.61409/v11230715 · Cited by 3
Antiphospholipid syndrome
Sciascia, S., Radin, M., & Schreiber, K. I. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23947-2.00045-x · Cited by 3
Republished review: Ocular manifestations of the antiphospholipid syndrome
Utz, V. M., & Tang, J. C. O. (2011) · Postgraduate Medical Journal · doi:10.1136/pgmj.2010.182857rep · Cited by 3
Clinical Management of Antiphospholipid Syndrome-Related Thrombosis
Espinosa, G., & Cervera, R. (2010) · The Open Autoimmunity Journal · Cited by 3
Direct Oral Anticoagulant Use in Atypical Thrombosis-Related Conditions
Chang, C., Hoyos, M., Owusu, Y., & Elewa, H. F. (2017) · Annals of Pharmacotherapy · doi:10.1177/1060028017731850 · Cited by 3
Thrombotic antiphospholipid syndrome
Sciascia, S., & Radin, M. (2018) · Lupus · doi:10.1177/0961203318801686 · Cited by 3
ANTIPHOSPHOLIPID SYNDROME
Avčin, T., & O’Neil, K. M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-6581-4.10022-6 · Cited by 3
Dorsolateral medullary infarction during skin infection by Stenotrophomonas maltophilia in a patient with triple antiphospholipid antibody positivity: a case-based review
Chen, Y., Yang, H., Liu, L.-X., Chen, C.-H., Qin, H., Hong, X., Zhao, J., & Liu, D. (2020) · Clinical Rheumatology · doi:10.1007/s10067-020-05489-3 · Cited by 3
Secondary Antiphospholipid Syndrome
Rahman, A., & Raimondo, M. G. (2014) · Rare diseases of the immune system · doi:10.1007/978-3-319-11044-8_19 · Cited by 3
What are the prospects for antiplatelet agents for thromboprophylaxis in antiphospholipid syndrome?
Ruiz‐Irastorza, G., & Khamashta, M. A. (2022) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2022.2090338 · Cited by 3
Antiphospholipid Syndrome: Thrombotic and Vascular Complications
Windisch, S., Ash, J. Y., & Frishman, W. H. (2023) · Cardiology in Review · doi:10.1097/crd.0000000000000590 · Cited by 4
Efficacy and safety of direct oral anticoagulants compared with warfarin in antiphospholipid syndrome. Results of a multicenter retrospective cohort study
Elsebaie, M. A., Wickham, Z. A., Debragga, S., Fedewa, S. A., Amgad, M. T., Park, J. J., Li, A., Eshaghpour, A., Li, J., Crowther, M., et al. (2025) · Research and Practice in Thrombosis and Haemostasis · doi:10.1016/j.rpth.2025.102856 · Cited by 2
Monitoring heparin in patients with a lupus anticoagulant: detection of heparin resistance
TRENFIELD, S., Parmar, K., & Hunt, B. J. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.03151.x · Cited by 2
An update on current management strategies for antiphospholipid syndrome‑related thrombosis
Rossi, A., Colorio, C. C., Puente, D., & Forastiero, R. R. (2014) · Clinical Lipidology · doi:10.2217/clp.13.85 · Cited by 3
Paediatric Antiphospholipid Syndrome
Toplak, N., & Avčin, T. (2016) · Technical report · doi:10.1016/b978-0-444-63655-3.00010-7 · Cited by 2
Could Anticoagulation or Antiaggregation Treatment Be Ceased in Patients With Primary Antiphospholipid Syndrome When Antiphospholipid Antibodies Become Persistently Negative?
Hindilerden, F., Hindilerden, İ. Y., & Küçükkaya, R. D. (2017) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0000000000000538 · Cited by 2
Systemic lupus erythematosus: a case-based presentation of renal, neurologic, and hematologic emergencies
Campbell, E. J., Clarke, A. E., & Ramsey‐Goldman, R. (2018) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2018.1518132 · Cited by 2
Pediatric Antiphospholipid Syndrome
Avčin, T., & Cimaz, R. (2016) · Technical report · doi:10.1016/b978-0-444-63596-9.00018-9 · Cited by 2
Antiphospholipid Syndrome
Bermas, B. L. (2012) · Springer eBooks · doi:10.1007/978-1-4614-1189-5_15 · Cited by 2
Perioperative Management of Antiphospholipid Antibody Positive Patients During Noncardiac Surgeries
Saunders, K. H., & Erkan, D. (2012) · Springer eBooks · doi:10.1007/978-1-4614-2203-7_8 · Cited by 2
Successful treatment with thrombolysis and stent in acute limb ischemia complicating antiphospholipid syndrome
Moulinet, T., Risse, J., Frédéric, M., Blum, A., Zuily, S., & Wahl, D. G. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.03.139 · Cited by 2
Acute Myocardial Infarction Involving Left Main Artery in a Patient with Antiphospholipid Syndrome.
Wang, W.-H., Chen, Y., & Hsieh, M. H. (2019) · Europe PMC (PubMed Central) · doi:10.6515/acs.201911_35(6).20190829a · Cited by 2
Neurovascular Consequences of Systemic Disease: Lupus and Primary Hyperparathyroidism
Sum, M., Kapoor, T. M., & Walker, M. D. (2020) · Springer eBooks · doi:10.1007/978-3-030-49586-2_14 · Cited by 2
Right Ventricular Outflow Tract Mass in Antiphospholipid Syndrome
Sahebjam, M., Poorhosseini, H., Hajiali, A., Gholizad, T. M., & Mohammadzadeh, S. (2025) · Clinical Case Reports · doi:10.1002/ccr3.70784 · Cited by 1
Prevalence, incidence proportion and independent predictors of thromboembolic events in adults with antiphospholipid syndrome: A systematic review with meta-analysis
Essouma, M., Nkeck, J. R., Agbor, V. N., Tchaptchet, P., Dalle, U. D., Yondo, J. C. N., Tchouda, L. A. S., Momo, Y. C. B., Akoa, D. A., & Nkeck, J. P. (2026) · Phlebology The Journal of Venous Disease · doi:10.1177/02683555251413935 · Cited by 1
Chronic Limb‐Threatening Ischemia Owing to Popliteal Artery Aneurysms With Repeated Occlusion After Stent Graft Placement That was Successfully Treated With Supera Stent Reinforcement: A Case Report
Miwa, H., Hayakawa, N., Tsurumaki, T., Tsuchida, Y., Ichihara, S., Maruta, S., & Kushida, S. (2026) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.70548 · Cited by 1
Síndrome de anticuerpos antifosfolípidos asociado a la presencia de inhibidor adquirido del factor IX en una paciente sin hemofilia
Chalem, P. (2019) · Acta Médica Colombiana · doi:10.36104/amc.2011.1449 · Cited by 1
Syndrome des antiphospholipides
Meyer, O. (2010) · EMC - Appareil locomoteur · doi:10.1016/s0246-0521(10)52466-5 · Cited by 1
Recurrent pulmonary embolism in a boy with antiphospholipid syndrome
Müller, C., Willaschek, C., Borst, M. M., & Buchhorn, R. (2013) · Case Reports in Clinical Medicine · doi:10.4236/crcm.2013.25083 · Cited by 1
Monitoring plasma heparin concentration in a patient with antiphospholipid syndrome
Inaba, T., Yuki, Y., Nishino, S., Komatsu, S., Ishino, H., Tsuji, H., & Fujita, N. (2010) · International Journal of Hematology · doi:10.1007/s12185-010-0508-x · Cited by 1
Recent advances in pathogenesis and pathophysiology in the antiphospholipid syndrome
Horita, T. (2012) · Japanese Journal of Clinical Immunology · doi:10.2177/jsci.35.481 · Cited by 1
Current treatment strategies for management of antiphospholipid syndrome
Reggia, R., Andréoli, L., Tincani, A., & Shoenfeld, Y. (2014) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2014.881734 · Cited by 1
Conventional Treatment of Systemic Lupus Erythematosus
Quattrocchio, G., Fervenza, F. C., & Roccatello, D. (2016) · Rare diseases of the immune system · doi:10.1007/978-3-319-24535-5_16 · Cited by 1
Successful Anticoagulation Therapy for Antiphospholipid Syndrome with Mobile Aortic Thrombi
Park, H. O., Moon, S. H., Kim, J. W., Byun, J. H., Kim, S. H., Yang, J. H., Lee, C. E., & Kim, J.-D. (2016) · Vascular Specialist International · doi:10.5758/vsi.2016.32.4.186 · Cited by 1
Recurrent ST-elevation Myocardial Infarction in a Patient with Systemic Lupus Erythematosus
Adar, A., Çakan, F., Önalan, O., & Okutucu, S. (2017) · Journal of Thrombosis and Circulation Open Access · doi:10.4172/2572-9462.1000123 · Cited by 1
Task Force Report on the Management of Thrombosis in Antiphospholipid Syndrome
Ruiz‐Irastorza, G., Pengo, V., Tektonidou, M. G., Ruiz‐Arruza, I., Cuadrado, M. J., & Khamashta, M. A. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3194-7_11 · Cited by 1
Varfarin v terapii antifosfolipidnogo sindroma
Reshetnyak, T. M., Kondrateva, L., Shtivelband, I. B., & Nasonov, E. L. (2008) · Modern Rheumatology Journal · doi:10.14412/1996-7012-2008-469 · Cited by 1
Síndrome de anticuerpos antifosfolípidos
Mathian, A., Hié, M., Pha, M., & Amoura, Z. (2020) · EMC - Tratado de Medicina · doi:10.1016/s1636-5410(20)44023-1 · Cited by 1
Antiphospholipid syndrome
Khamashta, M. A., Pierangeli, S. S., & Harris, E. N. (2011) · Elsevier eBooks · doi:10.1016/b978-0-323-06551-1.00135-4 · Cited by 1
Lupus and the nervous system
Legge, A. C., & Hanly, J. G. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-93232-5.00044-7 · Cited by 1
Aspirina frente a anticoagulación en pacientes jóvenes con infarto cerebral secundario a síndrome antifosfolípido primario
Araúz, A., Roa, L. F., Curiel, B. H., Benítez, M. M., Márquez-Romero, J. M., Gómez, C. A., Ruiz, A. P., Brito, C. C., & Aldatz, F. B. (2011) · Revista de Neurología · doi:10.33588/rn.5310.2011356 · Cited by 1
Antiphospholipid Syndrome (APS) - An Update on Clinical Features and Treatment Options
Umer, S., Katikaneni, M., Gangam, M., & Berney, S. M. (2015) · The Open Urology & Nephrology Journal · doi:10.2174/1874303x01508020027 · Cited by 1
Antiphospholipid Syndrome On Cloud (APSOnCloud): web-based monitoring of oral anticoagulation
Nogueira, F., Signorelli, F., & Levy, R. A. (2016) · Lupus · doi:10.1177/0961203316658558 · Cited by 1
Hematologic Disorders and Stroke
Bushnell, C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-29544-4.00042-6 · Cited by 1
Efficacy of dual antiplatelet therapy for preventing recurrence of arterial thrombosis in patients with antiphospholipid syndrome
Fujieda, Y. (2019) · Japanese Journal of Thrombosis and Hemostasis · doi:10.2491/jjsth.30.669 · Cited by 1
Recommendations of the Spanish Rheumatology Society for primary antiphospholipid syndrome. Part I: Diagnosis, evaluation and treatment
Cáliz, R., Fontecha, P. D. D. C., Galindo-Izquierdo, M., Longo, F. J. L., Zamora, M. Á. M., Santamaría, A., Pliego, O. A., Lozano, M. J. C., Beltrán, M. P. D., Ortells, L. C., et al. (2019) · Reumatología Clínica (English Edition) · doi:10.1016/j.reumae.2018.11.012 · Cited by 1
Suspensión de la anticoagulación en pacientes con síndrome antifosfolipídico primario en los que se negativizan los anticuerpos antifosfolipídicos
Rodríguez-Fernández, S., Ramírez, P. S., Garriga, G. E., & Segura, R. C. (2009) · Revista Clínica Española · doi:10.1016/s0014-2565(09)71823-5 · Cited by 1
Management of APS
Bertolaccini, M. L., Ateka–Barrutia, O., & Khamashta, M. A. (2009) · Springer eBooks · doi:10.1007/978-1-84628-735-0_10 · Cited by 1
The Nervous System in Systemic Lupus Erythematosus
Hanly, J. G. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801917-7.00047-4 · Cited by 1
Antiphospholipıd Syndrome and Venous Thrombosis
Okuyan, E. (2012) · InTech eBooks · doi:10.5772/27128
Venous Thrombosis and the Eye
Bob, Z., & Celia, S. (2012) · InTech eBooks · doi:10.5772/29218
Neurological complications of systemic disorders
Scott, B. J. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511736193.011
Chapter 10 Pediatric Antiphospholipid Syndrome
Avčin, T., & Cimaz, R. (2009) · Technical report · doi:10.1016/s1571-5078(08)00410-8
Estudo da trombose microvascular em biópsias pulmonares de pacientes com granulomatose de Wegener
Santana, A. N. C. (2008) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2008.tde-10102008-152122
Antiphospholipid Syndrome - An Evolving Story of a Multisystemic Disease
Silvia, S., Willis, R., Harper, B. E., & Manoharan, E. N. E. A. (2012) · InTech eBooks · doi:10.5772/36714
Chapter 15 Treatment of Thrombosis in the Antiphospholipid Syndrome
Ruiz‐Irastorza, G., & Khamashta, M. A. (2009) · Technical report · doi:10.1016/s1571-5078(08)00415-7
Update on Antiphospholipid Antibody Syndrome Management
Manganelli, R., Iannaccone, S., Manganelli, S., & Iannaccone, M. (2012) · InTech eBooks · doi:10.5772/31724
Optic neuropathy in a pregnant patient with antiphospholipid syndrome
Asorey-García, A., Santos-Bueso, E., Saenz-Frances, F., & García-Feijoo, J. (2015) · Neurología (English Edition) · doi:10.1016/j.nrleng.2015.08.005
Branch Retinal Artery Occlusion as a Presenting Feature of Anti-Phospholipid Antibody Syndrome and Homocysteinemia
Agarwal, R., Veerwal, V., Jain, P., Goyal, J. L., & Jain, N. (2015) · Delhi Journal of Ophthalmology · doi:10.7869/djo.132
Heart failure with multi-organ thrombosis: a case of antiphospholipid syndrome co-existing with cardiomyopathy
Zhong, L., Yang, L., Li, X., & Wei, S. (2012) · Russian Open Medical Journal · doi:10.15275/rusomj.2012.0204
Primary Antiphospholipid Antibody Syndrome Presenting as Recurrent Deep Vein Thrombosis
Khan, A. M., & Banoo, H. (2014) · Bangladesh Journal of Medical Science · doi:10.3329/bjms.v13i2.18307
Trombosis arterial y venosa como primera manifestación de síndrome antifosfolípido en paciente octogenaria
Jiménez, V. H., Muñoz, V. M., Izquierdo, J. R., & Pérez, I. S. (2013) · Revista Española de Geriatría y Gerontología · doi:10.1016/j.regg.2013.06.004
Tout est dans toux…
Taillé, C., & Crestani, B. (2008) · Revue des Maladies Respiratoires · doi:10.1016/s0761-8425(08)56005-0
Systemic Thromboembolism in Pregnancy: Cerebrovascular Disease
Arachchillage, D. J., O’Brien, P., Davie, C., & Cohen, H. (2015) · Springer eBooks · doi:10.1007/978-3-319-15120-5_6
Neuropatía óptica en gestante con síndrome antifosfolípido
Asorey-García, A., Santos-Bueso, E., Saenz-Frances, F., & Garcia-Sanchez, J. (2014) · Neurología · doi:10.1016/j.nrl.2014.03.009
Alfredo Nicodemos da Cruz Santana Estudo da trombose microvascular em biópsias pulmonares de pacientes com granulomatose de Wegener
Paulo, S. (2008)
Síndrome de anticuerpos antifosfolípidos asociado a la presencia de inhibidor adquirido del factor IX en una paciente sin hemofilia Antiphospholipid antibody syndrome associated with acquired factor IX inhibitor in a non- hemophilic patient
Chalem, P. (2011)
Antiphospholipid syndrome in terms of cardiovascular surgery
Uyar, İ. S. (2015) · Turkish Journal of Thoracic and Cardiovascular Surgery · doi:10.5606/tgkdc.dergisi.2015.10280
New Concept of Clinical Pathology and Treatment of Antiphospholipid Syndrome
Horita, T., & Koike, T. (2008) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.97.1334
Antiphospholipid Antibody Syndrome
(2012) · Springer eBooks · doi:10.1007/springerreference_188000
2. Antiphospholipid Syndrome
Yasuda, S. (2013) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.102.2621
Prognosis in Antiphospholipid Syndrome
Serrano, R. M., Pons‐Estel, G., Espinosa, G., & Cervera, R. (2016) · Technical report · doi:10.1016/b978-0-444-63655-3.00019-3
Antiphospholipid Antibody Syndrome in Childhood
Avramovič, M. Z., & Avčin, T. (2016) · Springer eBooks · doi:10.1007/978-981-10-1750-6_28
Triple therapy in a young patient with antiphospholipid syndrome after ST-segment elevation myocardial infarction
Mišković, D., Prvulović, Đ., Vujeva, B., Hadžibegović, I., Gabaldo, K., & Menegoni, M. (2016) · Cardiologia Croatica · doi:10.15836/ccar2016.450
APS and the Nervous System
Chighizola, C. B., Sangalli, D., Corrà, B., Silani, V., & Adobbati, L. (2014) · Rare diseases of the immune system · doi:10.1007/978-3-319-11044-8_8
An unusual case of heart attack
Young, J. K.-Y., & Ng, D. K. H. (2018) · Hong Kong bulletin on rheumatic diseases · doi:10.2478/hkbrd-2018-0004
Quelles sont les particularités thérapeutiques au cours du syndrome des antiphospholipides ?
Benhamou, Y., Delluc, A., Am, F., & Sanchez, O. (2019) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2019.05.017
The kidney in rheumatological disorders
Lightstone, L., & Beckwith, H. (2020) · doi:10.1093/med/9780198746690.003.0493
Management of antiphospholipid syndrome in adults: The European League Against Rheumatism (EULAR) recommendations
Veselinović, M., Lucic, A. T., Jakovljevic, V. L., & Aničić, A. (2019) · Medicinski casopis · doi:10.5937/mckg53-23292
Treatment of neuropsychiatric lupus
Hanly, J. G., Omisade, A., & Fisk, J. D. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-09138-1.00135-2
[Mechanisms and management of thrombosis and bleeding in antiphospholipid syndrome].
Wang, Z. (2017) · PubMed Central · doi:10.3760/cma.j.issn.0253-2727.2017.11.022
Sindrome da anticorpi antifosfolipidi
Mathian, A., Hié, M., Pha, M., & Amoura, Z. (2020) · EMC - AKOS - Trattato di Medicina · doi:10.1016/s1634-7358(20)44131-2
Treatment of Antiphospholipid Syndrome
Sciascia, S., & Khamashta, M. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801917-7.00063-2
Treatment of Thrombosis in Antiphospholipid Syndrome
Braham, S., Bucciarelli, P., & Moia, M. (2014) · Rare diseases of the immune system · doi:10.1007/978-3-319-11044-8_15
Hematologic Disorders and Stroke
Lisle, B., & Bushnell, C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-69424-7.00042-9
National consensus on systemic lupus erythematosus
Rashkov, R. K., Monov, S. V., Ivanova, M. G., Kalinova, D., Stoilov, N. R., & Zdravkova, Y. (2020) · Rheumatology (Bulgaria) · doi:10.35465/29.s.2021.pp3-25
Current World Literature
(2009) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e3283304c7b
Nervous system
Hanly, J. G., Omisade, A., & Fisk, J. D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820583-9.00030-0
Antiphospholipid Syndrome
Watson, H. G., & Crowther, M. A. (2016) · Wiley eBooks · doi:10.1002/9781118344729.ch19

Authors: Ruiz‐Irastorza, G., Hunt, B. J., & Khamashta, M. A.
Affiliations: University of the Basque Country (ES)
St Thomas' Hospital (GB)
ORCID: Ruiz‐Irastorza, Guillermo
Hunt, Beverley J.
Khamashta, Munther A.
Venue: Arthritis Care & Research
Publisher: Wiley
Published: 2007-11-29
Volume: 57
Issue: 8
Pages: 1487-1495
ISSN: 0893-7524 (ISSN-L)
1529-0123
DOI: 10.1002/art.23109
OpenAlex: W2160198109
Cited by: 324
References: 40
Citations by year: 2026: 4 · 2025: 6 · 2024: 12 · 2023: 11 · 2022: 6 · 2021: 10 · 2020: 19 · 2019: 20 · 2018: 14 · 2017: 16 · 2016: 28 · 2015: 27 · 2014: 20 · 2013: 19 · 2012: 27
FWCI: 2.58
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: Arthritis Care & Research (publishedVersion)
PubMed (publishedVersion)
Research Portal (King's College London) (submittedVersion)
Topics: Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
Keywords: antiphospholipid antibodies, antiphospholipid syndrome, warfarin, oral anticoagulation, international normalized ratio, venous thromboembolism, arterial thrombosis, stroke, recurrent thrombosis, bleeding risk, low-dose aspirin
MeSH terms: Anticoagulants, Aspirin, Humans, Platelet Aggregation Inhibitors, Thrombosis, Warfarin, Antiphospholipid Syndrome, Antibodies, Antiphospholipid, International Normalized Ratio

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks